ArticleInfection and drug resistance2022
Severe
Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 20 citations in OpenAlex.
- Current status and challenges in the diagnosis and treatment of psittacosis.Infectious diseases & immunity · 2026Review
- Rapid diagnosis ofExperimental and therapeutic medicine · 2026Article
- Observational
- Review
- Clinical characterization ofFrontiers in medicine · 2026Article
- A case of psittacosis pneumonia complicated by rhabdomyolysis.World journal of emergency medicine · 2026Article
- Incidence, clinical characteristics, and risk factors of acute kidney injury in patients withFrontiers in cellular and infection microbiology · 2026Article
- Early diagnosis and therapy of Chlamydia psittaci pneumonia: insights from chest CT, tNGS, and omadacycline in 34 cases.Frontiers in medicine · 2026Article
- Clinical management and pharmaceutical care of severeFrontiers in cellular and infection microbiology · 2026Review
- Clinical Features and Risk Factors for Rhabdomyolysis in Patients withInfection and drug resistance · 2026Article
- Clinical characteristics ofFrontiers in medicine · 2025Article
- SevereFrontiers in medicine · 2025Article
- Case Report: Severe psittacosis in an elderly patient without avian exposure: diagnosis via metagenomic next-generation sequencing and rapid response to doxycycline.Frontiers in medicine · 2025Article
- Review
- Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China.BMC infectious diseases · 2024Article
- Evaluation of clinical characteristics and risk factors associated with Chlamydia psittaci infection based on metagenomic next-generation sequencing.BMC microbiology · 2024Article
- Analysis and Perception ofInfection and drug resistance · 2024Article
- Clinical Features and a Prediction Model for Early Prediction of Composite Outcome inInfection and drug resistance · 2024Article
- Diagnosis of a Familial Psittacosis Outbreak with Clinical Analysis and Metagenomic Next-Generation Sequencing Under COVID-19: A Case Series.Infection and drug resistance · 2024Article
- Pneumonia Caused byInternational medical case reports journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To explore the clinical characteristics, diagnosis, and treatment of severe Patients and Methods: The clinical characteristics, diagnosis, treatment, and outcomes of four patients with severe Results: All four patients were male, aged 46-64 years, and all had a history of bird contact. All patients had fever, fatigue, tea-colored urine, myalgia, and two patients were unable to walk. Conclusion: Psittacosis complicated by rhabdomyolysis is characterized by fever, fatigue, myalgia, and tea-colored urine, with significant increases in creatine kinase and myoglobin. The McMahon score should be applied early to assess the risk of acute kidney injury, and renal replacement therapy and renal protection therapy should be initiated in the early stage. Among severely ill patients, early use of empirical antibiotics, including quinolones, may improve the prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.